| Having trouble viewing this email? View as Webpage |
|
APRIL 2026 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
|
 |
Rewiring Psychiatry: Inside a Bold Push to Transform Mental Health Science
|
|
For centuries, physicians have tested whether physical interventions could cure mental illness. Most of these interventions failed, however, and were replaced with the current standard of treatment: medications and therapy. That’s because many of the biological underpinnings of mental health still remain a mystery. At Feinberg, an invigorated Department of Psychiatry and Behavioral Sciences is working to change that.
Read the Feature
|
|
 |
Feinberg Faculty Inducted into Prominent Honor Societies
|
|
Five Feinberg faculty members have been inducted into the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP), two of the oldest medical honor societies in the U.S. Read about faculty awarded
|
|
 |
Save the Date for Research Day: September 10
|
|
Our annual Research Day is a campuswide event to promote faculty, staff, student and trainee development through the sharing of recent research and conversation with colleagues. Our 2026 event will be held on Thursday, September 10. More information will be forthcoming about abstract submissions in July. Learn more about Research Day
|
|
Faculty Profile
Investigating the Molecular Basis of Parkinson’s Disease
Loukia Parisiadou, PhD, is an assistant professor of Pharmacology. Her research aims to elucidate the cellular and molecular events by which mutations in genes linked to Parkinson’s disease contribute to disease pathology by using cell-type-specific approaches.
Read more about her research
|
|
|
Staff Profile
Facilitating Research Support and Grant Proposals
Allison Cholewa is a research administrator within the Institute for Public Health and Medicine (IPHAM). She started at Feinberg as a financial assistant and quickly found herself embedded in research administration and support. In her current role, she creates grant proposals and manages existing grants and contracts.
Check out the full profile
|
|
|
Addressing Youth Mental Health Concerns with Implementation Science
Katie Cohen is a PhD candidate in the Health Sciences Integrated PhD Program (HSIP) at Feinberg. Her research interests focus on improving youth mental health by creating and implementing innovative, accessible, evidence-based solutions.
Learn more about her research
|
|
|
|
|
|
Tue
Apr 21
|
Chicago - 12:15 PM - 1:15 PM
|
|
Wed
Apr 22
|
Chicago - 10:00 AM - 11:00 AM
|
|
Thu
Apr 23
|
Chicago - 12:00 PM - 1:00 PM
|
|
Fri
Apr 24
|
Chicago - 1:00 PM - 3:00 PM
|
|
|
|
|
Postdoctoral Scientists: Apply for T32 Funding by May 1
The Enhancing TRanslational science to Accelerate Impact of New innovations (E-TRAIN) program is accepting applications, due May 1, 2026.
This program aims to catalyze the careers of postdoctoral scientists, who will expand their domain expertise through mentored research with increasing independence while developing foundational skills in boundary-crossing, interdisciplinary team science. E-TRAIN is funded as part of the Clinical and Translational Science Award program, supported by the National Center for Advancing Translational Sciences.
Learn more
|
|
|
Improving Testing and Diagnosis of Hepatitis C with Claudia Hawkins, MD, MPH
A new, rapid Hepatitis C test developed by Northwestern University scientists could change the future of care by delivering faster diagnosis and treatments. In this episode, Hawkins explains this research and the impact this test could have on the global effort to eliminate Hepatitis C.
Listen to the podcast episode
|
|
|
New Faculty
Farrah J. Mateen, MD, PhD, joined Feinberg in April 2025 as the Dr. Charles L. Mix Research Professor of Neurology. Her research focuses on advancing the understanding multiple schlerosis (MS) and related diseases to identify new treatments and develop biomarkers for patients. Additionally, from a global health perspective, she is interested in investigating the burden of neurological diseases, particularly in resource-limited settings in Africa and Asia. Her long-term goal is to enhance neurological care through testing, evidence-based interventions, driven by clinical research. Prior to coming to Northwestern, she served as an associate professor of Neurology at Harvard Medical School and an associate neurologist at Massachusetts General Hospital.
|
|
|
Galter Library
NIH Common Forms in SciENcv: Working Toward a Smooth Transition
The National Institutes of Health (NIH) introduced a requirement for all applications dated on or after January 25, 2026 to use the NIH Common Forms for the biographical sketch and the Current and Pending Other Support (CPOS) documents.
Read about the requirements
|
|
|
High Impact Research
Billingham LK, DeLay SL, Eshac Y, Chia TY, Tripathi S, Olson IE, Zilinger K, Subbiah J, Wang Z, Sadagopan NS, Najem H, Cognet G, Katz JL, Du R, Nandoliya KR, Boland LK, Ignacio Vázquez-Cervantes G, Wang S, Wan H, Lipshutz AB, Murphy AR, Duffy J, Balyasnikova IV, Zhang P, Heiland DH, Ahmed AU, Lee-Chang C, Heimberger AB, Perry JSA, Muir A, Chandel NS, Miska J. Microglial fructose metabolism is essential for glioblastoma growth. Proceedings of the National Academy of Sciences of the United States of America. Mar 2026; 123(12):e2521256123.
Chen K, Wang W, Lennon A, McClure RA, Vuchkovska A, Kelley SO, Wang Z. Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle-mediated mRNA delivery in preclinical models. Science Translational Medicine. Mar 2026; 18(840):eadx4097.
Chou WC, Lakonishok M, Lu W, Gelfand VI, McCartney BM. Developmentally regulated actin-microtubule cross talk in Drosophila oogenesis. The Journal of Cell Biology. Mar 2026; 225(3).
Colman H, Lombardi G, Wong ET, Walbert T, Eoli M, Lassman AB, Peereboom DM, Kizilbash SH, Kamiya-Matsuoka C, Pitz MW, Strowd RE, Desjardins A, Kumthekar P, Mason W, Pellerino A, Soffietti R, Butowski N, Forsyth PA, Hamza MA, Hau P, Lallana E, Nabors B, Piccioni D, Uhlmann EJ, Welsh LC, Wen PY, Dietrich J, Wang C, Levin VA. STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma. Journal of Clinical Oncology. Mar 2026; 44(8):641-652.
Review More Publications
|
|
Analytical bioNanoTechnology Equipment Core (ANTEC)
The Analytical bioNanoTechnology Equipment Core (ANTEC) houses research equipment for evaluating materials and biological preparations and offers 3D printing and 3D scientific illustration services. The core serves Northwestern University researchers, visiting scientists and local industry researchers.
You can more about the services and equipment offered on the website.
Learn more about ANTEC
|
|
|
|
|
|
|
|
